Figure 5From: Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study Arithmetic mean plasma concentration of lesogaberan. Lesogaberan was administered as doses of 30, 90, 120 or 240 mg twice daily (b.i.d.) over a period of 24 h (pharmacokinetics analysis set).Back to article page